Review




Structured Review

AID Diagnostika aid elispot reader
Aid Elispot Reader, supplied by AID Diagnostika, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/aid+elispot+reader/pmc02842242-135-5-8
Average 90 stars, based on 1 article reviews
aid elispot reader - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

other:

Article Title: Alphaviral genetic background of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen.
Article Snippet: The Mouse IFN- enzyme-linked immunosorbent spot (ELISpot) 530 kit (R&D systems #EL485, USA) was used to quantify the IFN- T cell response according to the 531 manufacturer’s instructions.

Article Title: Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replication
Article Snippet: Following a wash with PBS-T, biotinylated protein probes were added for 1.5 h at 37 °C (0.25 μg/mL goat anti-human IgG Fc fragment-specific antibody (Jackson ImmunoResearch, #109-065-008), 1 μg/mL WA-1 S/BA.5 S/WA-1 RBD/ovalbumin (OVA, Invivogen, #vac-stova)).

Enzyme-linked Immunospot:

Article Title: Coordinated early immune response in the lungs is required for effective control of SARS-CoV-2 replication.
Article Snippet: After another PBS-Twash, the developmentwas performedby adding nitro blue tetrazolium 5-bromo-4-chloro-3’ indolyphosphate substrate (Mabtech, #3650-10) for 7min atRT. .. The spotswere counted using an AID ELISpot reader (Autoimmun Diagnostika). .. Following a wash with PBS-T, biotinylated protein probes were added for 1.5 h at 37 °C (0.25μg/mL goat anti-human IgG Fc fragment-specific antibody (Jackson ImmunoResearch, #109-065-008), 1μg/mL WA-1 S/BA.5 S/WA-1 RBD/ovalbumin (OVA, Invivogen, #vac-stova)).

Article Title: A fusion protein that targets antigen-loaded extracellular vesicles to B cells enhances antigen-specific T cell expansion.
Article Snippet: Extracellular vesicles (EVs) have the potential to modulate immune responses via their cargo molecules and are being explored as vehicles in cancer immunotherapy.. Dendritic cell-derived EVs can induce antigen-specific immune responses leading to reduced tumor burden.. This response was shown to depend partially on B cells.

Article Title: Soluble CD52 mediates immune suppression by human seminal fluid.
Article Snippet: Wells were washed with PBS between sequential incubations with biotinylated anti-human IFN-g (1mg/ml), streptavidin-alkaline phosphatase (Mabtech) and 5-bromo-4-chloro-3-indolylphosphate/nitro blue tetrazolium substrate solution (Mabtech). .. The colour reaction was stopped by addition of water and IFN-g spots counted with an AID ELISpot Reader (Autoimmun Diagnostika Gmbh, Strassberg, Germany). ..

Article Title: Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses
Article Snippet: The cells were stimulated with the HA2 peptide array from the HA protein of A/Vietnam/1203/2004 (H5N1) (peptide 58–87, NR-18974, BEI Resources, Manassas, VA, USA). .. The number of spot-forming units (SFUs) was quantified by the AID EliSpot reader (Autoimmun Diagnostika, Straßberg, Germany). .. All statistical analyses were conducted by using GraphPad Prism software version 10.0.

Article Title: Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A Viruses.
Article Snippet: The cells were stimulated with the HA2 peptide array from the HA protein of A/Vietnam/1203/2004 (H5N1) (peptide 58–87, NR18974, BEI Resources, Manassas, VA, USA). .. The number of spot-forming units (SFUs) was quantified by the AID EliSpot reader (Autoimmun Diagnostika, Straßberg, Germany). .. All statistical analyses were conducted by using GraphPad Prism software version 10.0.

Article Title: The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box B
Article Snippet: Wells were washed with PBS between sequential incubations with biotinylated anti-human IFN-γ (1ug/ml), streptavidin-alkaline phosphatase (Mabtech) and 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium substrate solution (Mabtech). .. The color reaction was stopped by the addition of water and IFN-γ spots counted with an AID ELISpot Reader (Autoimmun Diagnostika Gmbh). .. CD52-Fc fusion protein (20μg) was cleaved with 2 μl of FXa protease (New England Biolabs) in a volume of 350 μl of water containing 2 mM of CaCl 2 .



Similar Products

99
Cellular Technology Ltd elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/ImmunoSpot+Software/pmc13654190-267-7-9
Average 99 stars, based on 1 article reviews
elispot reader - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cellular Technology Ltd elispot reader ctl s6 entry m2 analyzer
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader Ctl S6 Entry M2 Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Entry+M2/10__1038_slash_s41541___026___01527___4-210-14-21
Average 99 stars, based on 1 article reviews
elispot reader ctl s6 entry m2 analyzer - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Mabtech Inc astor elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Astor Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm42310741-96-14-17
Average 86 stars, based on 1 article reviews
astor elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc iris elispot fluorospot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Iris Elispot Fluorospot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pmc13260466-90-26-29
Average 86 stars, based on 1 article reviews
iris elispot fluorospot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm42150061-364-10-12
Average 86 stars, based on 1 article reviews
elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
Cellular Technology Ltd elispot reader s6 ultra m2
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader S6 Ultra M2, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Ultra+M2/bio_rxiv__64898__2026__03__18__712579-225-8-13
Average 99 stars, based on 1 article reviews
elispot reader s6 ultra m2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cellular Technology Ltd aid classic elispot plate reader
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Aid Classic Elispot Plate Reader, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Universal+M2/pmc12936837-401-18-23
Average 99 stars, based on 1 article reviews
aid classic elispot plate reader - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Mabtech Inc mabtech elispot reader
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Mabtech Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/bio_rxiv__64898__2026__03__12__711389-106-6-9
Average 86 stars, based on 1 article reviews
mabtech elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc elispot reader mabtech astortm2
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Elispot Reader Mabtech Astortm2, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm41796205-146-6-8
Average 86 stars, based on 1 article reviews
elispot reader mabtech astortm2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the ELISPOT assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).

Journal: Exploration

Article Title: A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity

doi: 10.1002/exp2.70238

Figure Lengend Snippet: Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the ELISPOT assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).

Article Snippet: Air‐dried plates were analyzed using an automated ELISPOT reader (Cellular Technology Ltd), and spot counts were quantified with ImmunoSpot software.

Techniques: In Vivo, Flow Cytometry, Analysis, Expressing, Co-culture Assay, Isolation, Enzyme-linked Immunospot, Cell Culture, CCK-8 Assay

Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo IFNγ-ELISpot well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.

Journal: iScience

Article Title: Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

doi: 10.1016/j.isci.2026.114917

Figure Lengend Snippet: Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo IFNγ-ELISpot well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.

Article Snippet: Plates were washed in double-distilled H 2 O and left to dry overnight before being read on the AID classic ELISpot plate reader (Immunospot S6 Universal M2 ELISpot Reader).

Techniques: Generated, Infection, Ex Vivo, Enzyme-linked Immunospot, Control, Membrane, Comparison, Whisker Assay

Failure of host T cells to recognize emerging virus (A) Ex vivo magnitude of the T cell response to individual ancestral sequence peptides in which mutation arose over persistent infection by IFNγ-ELISpot. (B) Magnitude of the CD4 and CD8 T cell responses after 10-day in vitro peptide expansion with individual ancestral sequence peptides. Percentage of CD4 and CD8 producing IFNγ, TNF, or both are shown. (C) Magnitude of IFNγ+, IFNγ+TNF+, and CTV lo IFNγ+ CD4 and CD8 T cells after 8-day expansion with a pool of 12 peptides corresponding to ancestral sequence epitopes or variant sequence epitopes containing mutations in the virus isolated at day 899 of infection. (D) Magnitude of the IFNγ+TNF+ CD4 or CD8 T cell response after 10-day in vitro peptide stimulation with individual epitopes using ancestral sequence or variant sequence peptides for culture and re-stimulation on day 9. Summary data showing all T cell responses that were detectable (left) or shown for individual peptides (right) for CD4 then CD8 T cells. Duplicate and triplicate stimulations are shown for CD8 T cells for M14 and NSP2, respectively. (D) Bars, mean. Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗∗ p ≤ 0.001. Peptide sequences shown in .

Journal: iScience

Article Title: Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

doi: 10.1016/j.isci.2026.114917

Figure Lengend Snippet: Failure of host T cells to recognize emerging virus (A) Ex vivo magnitude of the T cell response to individual ancestral sequence peptides in which mutation arose over persistent infection by IFNγ-ELISpot. (B) Magnitude of the CD4 and CD8 T cell responses after 10-day in vitro peptide expansion with individual ancestral sequence peptides. Percentage of CD4 and CD8 producing IFNγ, TNF, or both are shown. (C) Magnitude of IFNγ+, IFNγ+TNF+, and CTV lo IFNγ+ CD4 and CD8 T cells after 8-day expansion with a pool of 12 peptides corresponding to ancestral sequence epitopes or variant sequence epitopes containing mutations in the virus isolated at day 899 of infection. (D) Magnitude of the IFNγ+TNF+ CD4 or CD8 T cell response after 10-day in vitro peptide stimulation with individual epitopes using ancestral sequence or variant sequence peptides for culture and re-stimulation on day 9. Summary data showing all T cell responses that were detectable (left) or shown for individual peptides (right) for CD4 then CD8 T cells. Duplicate and triplicate stimulations are shown for CD8 T cells for M14 and NSP2, respectively. (D) Bars, mean. Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗∗ p ≤ 0.001. Peptide sequences shown in .

Article Snippet: Plates were washed in double-distilled H 2 O and left to dry overnight before being read on the AID classic ELISpot plate reader (Immunospot S6 Universal M2 ELISpot Reader).

Techniques: Virus, Ex Vivo, Sequencing, Mutagenesis, Infection, Enzyme-linked Immunospot, In Vitro, Variant Assay, Isolation